Compounds

Details Compounds Compounds

1998-05-20

2000-08-08

Martinell, James

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Recombinant dna technique included in method of making a...

4352523, 435325, 435455, 539 237, C12P 2102

Patent

active

061000604

ABSTRACT:
Wnt-5b polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing Wnt-5b polypeptides and polynucleotides in therapy, and diagnostic assays for such.

REFERENCES:
Critical Synergy: The Biotechnology Industry and Intellectual Property Protection, Biotechnology Industry Organization, Washington, DC, Oct. 17, 1994, pp. 75 and 100-107.
HGS EST #772353 No Date Available.
HGS EST #1324057 No Date Available.
HGS EST #1324064 No Date Available.
HGS EST #1372635 No Date Available.
HGS EST #1372634 No Date Available.
GenBank Accession #M89799.
P. Keene et al., "Abnormalities of chromosome 12p13 and malignant proliferation of eosinophils: a nonrandom association", British Journal of Haematology, vol. 67, pp. 25-31 (1987).
Gavin, B.J. et al., "Expression of multiple novel Wnt-1/int-1-related genes during fetal and adult mouse development", Genes & Development, vol. 4, pp. 2319-2332 (1990).
Cotter et al., "Abnormalities of Wnt signalling in schizophrenia-evidence for neurodevelopmental Abnormality", Neuroreport, vol. 9, pp. 1379-1383 (1988).
Copy of EP Search Report 98 30 3988.

Affiliated with

Also associated with

Rating

Compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1149062